Charles E. Protzman
Impact in
- Ophthalmology top 2%
- Glaucoma and retinal disorders
- Drug-Induced Ocular Toxicity
- Pharmacology top 2%
- Inflammatory mediators and NSAID effects
- Cannabis and Cannabinoid Research
Papers in
- Pharmacology 17
- Inflammatory mediators and NSAID effects 16
- Cannabis and Cannabinoid Research 2
- Biochemistry 11
- Eicosanoids and Hypertension Pharmacology 11
- Co-authors
- David F. Woodward (14 shared papers)Achim H.‐P. Krauss (16 shared papers)Amelia L. Nieves (5 shared papers)Robert M. Burk (8 shared papers)D.F. Woodward (4 shared papers)Clayton S. Spada (3 shared papers)STEPHEN B. HAWLEY (2 shared papers)Yuanbo Liang (3 shared papers)
- Journals
- British Journal of Pharmacology (3 papers)Journal of Pharmacology and Experimental Therapeutics (3 papers)Investigative Ophthalmology & Visual Science (2 papers)Journal of Ocular Pharmacology and Therapeutics (2 papers)Journal of Biological Chemistry (2 papers)
- Partner nations
- United StatesItalyUnited Kingdom
In The Last Decade
Charles E. Protzman
21 papers receiving 676 citations
Peers
Comparison fields: 5 of 45
- Ophthalmology 277
- Pharmacology 351
- Biochemistry 129
- Pharmaceutical Science 18
- Molecular Biology 142
Countries citing papers authored by Charles E. Protzman
This map shows the geographic impact of Charles E. Protzman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles E. Protzman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles E. Protzman more than expected).
Fields of papers citing papers by Charles E. Protzman
This network shows the impact of papers produced by Charles E. Protzman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles E. Protzman. The network helps show where Charles E. Protzman may publish in the future.
Co-authors
The 25 scholars most cited alongside Charles E. Protzman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2003 | 122 | |
| 2 | 2004 | 121 | |
| 3 | Studies on the ocular pharmacology of prostaglandin D2. | 1990 | 76 |
| 4 | 2003 | 70 | |
| 5 | 2006 | 52 | |
| 6 | 2004 | 37 | |
| 7 | 2000 | 34 | |
| 8 | 1993 | 32 | |
| 9 | 1993 | 32 | |
| 10 | Prostanoid-induced blood-aqueous barrier breakdown in rabbits involves the EP2 receptor subtype. | 1990 | 31 |
| 11 | 2000 | 30 | |
| 12 | 1996 | 21 | |
| 13 | 1995 | 20 | |
| 14 | 1994 | 19 | |
| 15 | 1995 | 9 | |
| 16 | 1997 | 9 | |
| 17 | 1994 | 2 | |
| 18 | 1993 | 1 | |
| 19 | Upregulation of Regulator of G Protein Signaling 5 (RGS5) in the Iris-Ciliary Body of Chronic Ocular Hypertensive Primates | 2002 | 1 |
| 20 | 2002 | 1 |
About Charles E. Protzman
Charles E. Protzman is a scholar working on Pharmacology, Biochemistry, Ophthalmology, Molecular Biology and Pharmaceutical Science, having authored 21 papers that have together received 721 indexed citations. Recurring topics across this work include Inflammatory mediators and NSAID effects (16 papers), Eicosanoids and Hypertension Pharmacology (11 papers), Glaucoma and retinal disorders (11 papers), Receptor Mechanisms and Signaling (7 papers), Cannabis and Cannabinoid Research (2 papers), Synthesis and biological activity (1 paper), Advanced Drug Delivery Systems (1 paper) and Protein Kinase Regulation and GTPase Signaling (1 paper). The work is most often cited by research in Ophthalmology (277 citations), Pharmacology (351 citations), Biochemistry (129 citations), Pharmaceutical Science (18 citations) and Molecular Biology (142 citations). Charles E. Protzman has collaborated with scholars based in United States, Italy and United Kingdom. Frequent co-authors include David F. Woodward, Achim H.‐P. Krauss, Amelia L. Nieves, Robert M. Burk, D.F. Woodward, Clayton S. Spada, STEPHEN B. HAWLEY, Yuanbo Liang, Karen M. Kedzie and Albert J. Evinger. Their work appears in journals such as British Journal of Pharmacology, Journal of Pharmacology and Experimental Therapeutics, Investigative Ophthalmology & Visual Science, Journal of Ocular Pharmacology and Therapeutics and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.